Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O L Laskin

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|October 1, 1992
Pharmacodynamics and tolerability of L-654,066, a steroid 5 alpha-reductase inhibitor, in menM Depré, C Meeter, A Van Hecken, et al.
The American Journal of Medicine|August 1, 1987
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirusO L Laskin, D M Cederberg, J Mills, et al.
Journal of the American Academy of Dermatology|April 1, 1989
Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndromeI H Gilson, J H Barnett, M A Conant, et al.
The American Journal of Medicine|July 20, 1982
Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failureH C Krasny, S H Liao, P de Miranda, et al.
The American Journal of Medicine|April 1, 1983
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infectionsJ L Abbruzzese, L E Rocco, O L Laskin, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
The American Journal of Medicine|July 20, 1982
Metabolic fate of radioactive acyclovir in humansP de Miranda, S S Good, H C Krasny, et al.
Clinical Pharmacology and Therapeutics|May 1, 1982
Acyclovir kinetics in end-stage renal diseaseO L Laskin, J A Longstreth, A Whelton, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Lancet (London, England)|February 20, 1982
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapyW H Burns, R Saral, G W Santos, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|October 1, 1992
Pharmacodynamics and tolerability of L-654,066, a steroid 5 alpha-reductase inhibitor, in menM Depré, C Meeter, A Van Hecken, et al.
The American Journal of Medicine|August 1, 1987
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirusO L Laskin, D M Cederberg, J Mills, et al.
Journal of the American Academy of Dermatology|April 1, 1989
Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndromeI H Gilson, J H Barnett, M A Conant, et al.
The American Journal of Medicine|July 20, 1982
Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failureH C Krasny, S H Liao, P de Miranda, et al.
The American Journal of Medicine|April 1, 1983
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infectionsJ L Abbruzzese, L E Rocco, O L Laskin, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
The American Journal of Medicine|July 20, 1982
Metabolic fate of radioactive acyclovir in humansP de Miranda, S S Good, H C Krasny, et al.
Clinical Pharmacology and Therapeutics|May 1, 1982
Acyclovir kinetics in end-stage renal diseaseO L Laskin, J A Longstreth, A Whelton, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Lancet (London, England)|February 20, 1982
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapyW H Burns, R Saral, G W Santos, et al.
Pageof 5